Showing results (891-900 of 1,066) with videos related to

Sort By:
Pageof 107
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 29, 2013
Do better-rated navigators improve patient satisfaction with cancer-related care?Pascal Jean-Pierre, Paul C Winters, Jack A Clark, et al.
Small Methods|February 22, 2023
Unraveling the Steric Link to Copper Precursor Decomposition: A Multi-Faceted Study for the Printing of Flexible ElectronicsShreya Mrig, Malavika A Bhide, Ye Zhou, et al.
Blood|January 1, 1981
Isolation and characterization of cloned DNA: the delta and beta globin genes in homozygous beta + thalassemiaA L Burns, S Spence, K Kosche, et al.
Leukemia Research|June 22, 2006
The spectrum of myelodysplastic syndromes post-solid organ transplantation: a single institutional experienceM Menes, E Vakiani, C E Keller, et al.
Nature Communications|April 26, 2020
Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic musclesChristine Péladeau, Nadine Adam, Lucas M Bronicki, et al.
Cell Reports|March 26, 2025
Therapeutic activation of IL-22-producing innate lymphoid cells enhances host defenses to Clostridioides difficile infectionKevin S Mears, Joshua E Denny, Jeffrey R Maslanka, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|October 25, 2018
A Research Agenda to Advance Pediatric Emergency Care Through Enhanced Collaboration Across Emergency DepartmentsIsabel Barata, Marc Auerbach, Oluwakemi Badaki-Makun, et al.
Arthroplasty Today|February 17, 2025
Dalbavancin Use in Bone and Joint InfectionsLiam P Alderson, Srivani Sanikommu, Simon C Mears, et al.
American Journal of Human Genetics|September 6, 2000
Remapping of the RP15 locus for X-linked cone-rod degeneration to Xp11.4-p21.1, and identification of a de novo insertion in the RPGR exon ORF15A J Mears, S Hiriyanna, R Vervoort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2005
A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancerM A Socinski, A Ivanova, K Bakri, et al.
Pageof 107